BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3025824)

  • 1. Neuropeptide Y (NPY) and the pig heart: release and coronary vasoconstrictor effects.
    Rudehill A; Sollevi A; Franco-Cereceda A; Lundberg JM
    Peptides; 1986; 7(5):821-6. PubMed ID: 3025824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
    Lundberg JM; Rudehill A; Sollevi A; Hamberger B
    Br J Pharmacol; 1989 Mar; 96(3):675-87. PubMed ID: 2566349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
    Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
    Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.
    Pernow J; Lundberg JM
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):379-85. PubMed ID: 2555719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prejunctional regulation of reserpine-resistant sympathetic vasoconstriction and release of neuropeptide Y in the pig.
    Modin A; Pernow J; Lundberg JM
    J Auton Nerv Syst; 1996 Feb; 57(1-2):13-21. PubMed ID: 8867080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
    Lacroix JS
    Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen.
    Lundberg JM; Rudehill A; Sollevi A; Theodorsson-Norheim E; Hamberger B
    Neurosci Lett; 1986 Jan; 63(1):96-100. PubMed ID: 3005926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Presynaptic regulation of co-release of neuropeptide Y and noradrenaline induced by electrical stimulation of the sympathetic nerve in guinea pig heart].
    Cheng B; Haass M; Richardt G; Schömig A
    Zhonghua Yi Xue Za Zhi; 1991 Oct; 71(10):564-7, 38. PubMed ID: 1665390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-adrenoceptor-mediated inhibition of nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig.
    Dahlöf C; Dahlöf P; Lundberg JM
    Eur J Pharmacol; 1986 Nov; 131(2-3):279-83. PubMed ID: 3028832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE; Lundberg JM
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
    Franco-Cereceda A; Lundberg JM; Dahlöf C
    Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart.
    Haass M; Cheng B; Richardt G; Lang RE; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):71-8. PubMed ID: 2566928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
    Pernow J; Kahan T; Lundberg JM
    Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.